What is the dosage of Onivyde?

Onivyde is available in 1 dosages, including 4.3 mg/ml Injection 10 ml

What does Onivyde treat?

Onivyde treats Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia, Lymphoma, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms and Stomach Neoplasms

What is Onivyde made of?

Onivyde contains irinotecan which is a Topoisomerase Inhibitor

How is Onivyde administered?

Onivyde is administered as a Injectable

What is Onivyde mechanism of action?

Onivyde mechanism of action is Topoisomerase Inhibitors

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Onivyde

(irinotecan)

10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]

BLACK BOX WARNING

Dosage & administration

* Do not substitute ONIVYDE for other drugs containing irinotecan HCl.
* Recommended dose of ONIVYDE is 70 mg/m2 intravenous infusion over 90 minutes every two weeks.
* Recommended starting dose of ONIVYDE in patients homozygous for UGT1A1*28 is 50 mg/m2 every two weeks.
* There is no recommended dose of ONIVYDE for patients with serum bilirubin above the upper limit of normal.
* Premedicate with a corticosteroid and an anti-emetic. 30 minutes prior to ONIVYDE.

drug label

Onivyde prescribing information

Have more Onivyde questions?

Submit MSL Request

Learn More

Need to report an Onivyde issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Onivyde samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Onivyde Prior authorization resources

Complete Letter of Medical Necessity

Coverage Authorization Request

Coverage Authorization Appeals

Medicare Part D Letter of Tier Change Request

Learn More

Benefits investigation

Ipsen Cares Program Enrollment

Ipsen Cares Program Enrollment - Online

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Onivyde Financial assistance options

Co-pay savings program

commercial only

Ipsen Cares Program Enrollment

Ipsen Cares Program Enrollment - Online

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Ipsen Cares Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Onivyde Patient education